Related Articles
The Legacy of Amyloid: Infiltration Linked to Dementia, Rheumatic Disease
An Unforgettable Story Her name was unforgettable. Not only did we share our given names—Simon and Simone, but her French-Canadian surname was based on this appellation, too. I was the junior resident working on our hospital’s nephrology service when she was admitted for evaluation of progressively worsening kidney disease and an overall failure to thrive….
Early Fall 2022’s Awards, Appointments & Announcements in Rheumatology
Roberto Caricchio, MD, Now Chief of Rheumatology at UMass Chan Medical School As of July 1, Roberto Caricchio, MD, began a new appointment as chief of the Division of Rheumatology at UMass Chan Medical School, Worcester. He was formerly chief of the Section of Rheumatology at Lewis Katz School of Medicine at Temple University, Philadelphia,…
A 52-Year-Old Lupus Paper Remains Important Today
Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythematosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…
Investigation Continues on Repurposed Rheumatology Therapies for COVID-19 Cytokine Storm
Roberto Caricchio, MD, discusses what trials of repurposed rheumatology drugs to treat COVID-19 cytokine storm have shown so far.